MENU
+Compare
MNKD
Stock ticker: NASDAQ
AS OF
Jul 28 closing price
Price
$3.96
Change
-$0.10 (-2.46%)
Capitalization
1.2B

MNKD MannKind Corp Forecast, Technical & Fundamental Analysis

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension... Show more

Industry: #Biotechnology
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MNKD with price predictions
Jul 28, 2025

MNKD in +4.52% Uptrend, rising for three consecutive days on July 22, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MNKD advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MNKD's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MNKD just turned positive on July 09, 2025. Looking at past instances where MNKD's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

MNKD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on July 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MNKD as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MNKD moved below its 50-day moving average on July 28, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNKD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MNKD entered a downward trend on July 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.071). P/E Ratio (39.600) is within average values for comparable stocks, (60.048). MNKD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.620). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (3.764) is also within normal values, averaging (281.754).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MNKD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MNKD is expected to report earnings to fall 28.57% to 5 cents per share on August 06

MannKind Corp MNKD Stock Earnings Reports
Q2'25
Est.
$0.05
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
The last earnings report on May 08 showed earnings per share of 7 cents, beating the estimate of 3 cents. With 2.26M shares outstanding, the current market capitalization sits at 1.20B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Casper Street
Phone
+1 818 661-5000
Employees
414
Web
https://www.mannkindcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIGFX38.28N/A
N/A
Victory Pioneer Fundamental Growth A
LMGYX34.76N/A
N/A
Lord Abbett Growth Opportunities I
EMCAX66.13N/A
N/A
Empiric Class A
LCIAX212.76N/A
N/A
SEI Large Cap Index A (SIIT)
DEQYX13.31N/A
N/A
BNY Mellon Global Equity Income - Y

MNKD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-2.46%
VCYT - MNKD
44%
Loosely correlated
-0.91%
LXRX - MNKD
42%
Loosely correlated
-0.91%
INSM - MNKD
40%
Loosely correlated
-2.12%
UTHR - MNKD
39%
Loosely correlated
-2.09%
CCCC - MNKD
37%
Loosely correlated
-3.54%
More